Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00159276
Status:
WITHDRAWN
Last Update Posted:
2024-04-04
First Post:
2005-09-08
Brief Title:
GR Defect in Sputum Cells in COPD
Sponsor:
Imperial College London
Organization:
Imperial College London
Study Overview
Official Title:
GR Defect in Sputum Cells in COPD
Status:
WITHDRAWN
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate a possible mechanism of the GR defect in patients with severe COPD by studying the effect of dexamethasone Dex on GR-GRE binding expression of inflammatory and anti-inflammatory factors such as IL-6 IL-8 MKP-1 GILZ SLPI production in sputum cells
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None